291 related articles for article (PubMed ID: 27097055)
1. Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats.
Liu G; Liu Y; Wang R; Hou T; Chen C; Zheng S; Dong Z
Cardiovasc Ther; 2016 Aug; 34(4):216-24. PubMed ID: 27097055
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways.
Barış VÖ; Dinçsoy AB; Gedikli E; Zırh S; Müftüoğlu S; Erdem A
Cardiovasc Toxicol; 2021 Sep; 21(9):747-758. PubMed ID: 34089496
[TBL] [Abstract][Full Text] [Related]
3. Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.
Li H; Mao Y; Zhang Q; Han Q; Man Z; Zhang J; Wang X; Hu R; Zhang X; Irwin DM; Niu G; Tan H
J Ethnopharmacol; 2016 Nov; 192():459-470. PubMed ID: 27586823
[TBL] [Abstract][Full Text] [Related]
4. Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity.
Feng K; Liu Y; Sun J; Zhao C; Duan Y; Wang W; Yan K; Yan X; Sun H; Hu Y; Han J
Biomed Pharmacother; 2021 Jun; 138():111531. PubMed ID: 34311530
[TBL] [Abstract][Full Text] [Related]
5. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats.
Imbaby S; Ewais M; Essawy S; Farag N
Hum Exp Toxicol; 2014 Aug; 33(8):800-13. PubMed ID: 24648241
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings.
Barış VÖ; Gedikli E; Yersal N; Müftüoğlu S; Erdem A
Amino Acids; 2019 Nov; 51(10-12):1649-1655. PubMed ID: 31673792
[TBL] [Abstract][Full Text] [Related]
8. The Protective Effects of Coenzyme Q10 and Lisinopril Against Doxorubicin-Induced Cardiotoxicity in Rats: A Stereological and Electrocardiogram Study.
Rahmanifard M; Vessal M; Noorafshan A; Karbalay-Doust S; Naseh M
Cardiovasc Toxicol; 2021 Nov; 21(11):936-946. PubMed ID: 34339022
[TBL] [Abstract][Full Text] [Related]
9. Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
Zhang S; Meng T; Liu J; Zhang X; Zhang J
Medicine (Baltimore); 2015 Jan; 94(4):e445. PubMed ID: 25634181
[TBL] [Abstract][Full Text] [Related]
10. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
[TBL] [Abstract][Full Text] [Related]
11. Concomitant low-dose doxorubicin treatment and exercise.
Sturgeon K; Schadler K; Muthukumaran G; Ding D; Bajulaiye A; Thomas NJ; Ferrari V; Ryeom S; Libonati JR
Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R685-92. PubMed ID: 25009215
[TBL] [Abstract][Full Text] [Related]
12. Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway.
Lin H; Zhang J; Ni T; Lin N; Meng L; Gao F; Luo H; Liu X; Chi J; Guo H
J Cell Mol Med; 2019 Sep; 23(9):6034-6047. PubMed ID: 31225944
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
14. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
[TBL] [Abstract][Full Text] [Related]
15. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.
Karhu ST; Kinnunen SM; Tölli M; Välimäki MJ; Szabó Z; Talman V; Ruskoaho H
Arch Toxicol; 2020 Jun; 94(6):2113-2130. PubMed ID: 32185414
[TBL] [Abstract][Full Text] [Related]
16. Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway.
Yan F; Liu R; Zhuang X; Li R; Shi H; Gao X
J Cardiovasc Transl Res; 2021 Apr; 14(2):355-364. PubMed ID: 32671648
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin-Potentiating Activity of a Gamma-Irradiated Bioactive Fraction Isolated from Scorpion (Leiurus quinquestriatus) Venom in Rats with Doxorubicin-Induced Acute Cardiotoxicity: Favorable Modulation of Oxidative Stress and Inflammatory, Fibrogenic and Apoptotic Pathways.
Ahmed LA; Abdou FY; El Fiky AA; Shaaban EA; Ain-Shoka AA
Cardiovasc Toxicol; 2021 Feb; 21(2):127-141. PubMed ID: 32860604
[TBL] [Abstract][Full Text] [Related]
18. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.
Bai Y; Chen Q; Sun YP; Wang X; Lv L; Zhang LP; Liu JS; Zhao S; Wang XL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28636290
[TBL] [Abstract][Full Text] [Related]
20. Empagliflozin prevents doxorubicin-induced myocardial dysfunction.
Sabatino J; De Rosa S; Tammè L; Iaconetti C; Sorrentino S; Polimeni A; Mignogna C; Amorosi A; Spaccarotella C; Yasuda M; Indolfi C
Cardiovasc Diabetol; 2020 May; 19(1):66. PubMed ID: 32414364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]